In late July, the CDC reported an investigation into the risk of tuberculosis from one contaminated donor lot for the bone-forming product ViBone and dental implant AlloOss, which were made by Silver Spring, Md.-based Aziyo Biologics. The company recalled all lots of its human bone tissue products July 13 after two patients contracted tuberculosis.
The CDC initially reported one patient death, and a second death was confirmed Aug. 11.
The contaminated lot was sent to healthcare facilities in California, Louisiana, Michigan, New York, Oregon, Texas and Virginia. The 34 other patients who have been treated with the material have been contacted, the CDC confirmed to Becker’s.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
